NR2B receptor antagonists for the treatment or prevention of migraines

Details for Australian Patent Application No. 2002346050 (hide)

Owner MERCK AND CO., INC.

Inventors Allen, Christopher; Sleeth, Timothy; Koblan, Ken, S.

Agent Spruson & Ferguson

Pub. Number AU-A-2002346050

PCT Number PCT/US02/21069

PCT Pub. Number WO2002/100352

Priority 60/297,672 12.06.01 US

Filing date 7 June 2002

Wipo publication date 23 December 2002

Event Publications

6 March 2003 Complete Application Filed

  Priority application(s): 60/297,672 12.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-A-2002346050

10 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002346051-APPARATUS AND METHOD TO MONITOR THE USAGE OF A NETWORK SYSTEM OF PERSONAL HAND SANITIZING DISPENSERS

2002346049-COACTIVATORS IN THE DIAGNOSIS AND TREATMENT OF BREAST CANCER